ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MACC1 Is Associated With Epithelial-Mesenchymal Transition and Can Predict Poor Prognosis in Nasopharyngeal Carcinoma

Cheng, Hao; Zhou, Linxiang; Long, Yalan; Xiang, Juanjuan; Chen, Longhua*南方医科大学; 1
Frontiers in Oncology2021-3-29DOI: 10.3389/fonc.2021.644120
7被引8阅读
引用收藏
分享

摘要

Background @@@ Given the reported correlation between the oncogene metastasis-associated in colon cancer 1 (MACC1) and nasopharyngeal carcinoma (NPC), as well as between MACC1 and epithelial-mesenchymal transition (EMT), we speculated that EMT is a likely causative link between MACC1 expression and poor NPC prognosis. Thus, we aim to clarify the relationship between MACC1 and EMT in NPC prognosis. @@@ Material and Methods @@@ We performed immunohistochemical examination of tissue sections from 128 NPC patients that were divided into six groups corresponding to high and low protein expression of MACC1 and two EMT-related proteins, vimentin and E-cadherin, and Kaplan-Meier (KM) survival analyses were performed. @@@ Results @@@ KM survival analysis showed that upregulation of MACC1 and vimentin and downregulation of E-cadherin were significantly associated with reduced survival in NPC. Short hairpin RNA (shRNA) interference and immunoblotting in the NPC cell line HNE-1 led to increased E-cadherin but decreased vimentin levels. MACC1 overexpression was significantly correlated with poor 5-year overall survival, metastasis-free survival, and disease-free survival (P<0.05) but not with poor relapse-free survival (P>0.05). Univariate analyses revealed that MACC1, E-cadherin, and vimentin levels along with T and N tumor classifications and cancer staging are significant prognostic factors of NPC (P<0.05). @@@ Conclusion @@@ Our findings showed the association between MACC1 and EMT in NPC malignancy and support the role of MACC1 as a prognostic biomarker and molecular target for NPC treatment.

学科与关键词

关键词
metastasis-associated in colon cancer 1 (MACC1)nasopharyngeal carcinomaepithelial-mesenchymal transition (EMT)vimentinE-cadherinprognostic biomarker
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2021-03-29
卷期
第 11 卷
页码
644120
DOI
10.3389/fonc.2021.644120
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
First People's Hospital of Chenzhou [N2018-003]

作者

  • C

    Cheng, Hao (第一作者)

    1 · southern med univ

  • Z

    Zhou, Linxiang

    1 · univ south china

查看全部 5 位作者收起作者
  • L

    Long, Yalan

    1 · univ south china

  • X

    Xiang, Juanjuan

    1 · univ south china

  • C

    Chen, Longhua (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417